Esophageal, Gastric & Duodenal Disorders
Thank you making our sessions at the 42nd annual DDW® in Chicago, IL scientifically relevant and exciting! If you have specific feedback regarding speakers sponsored by the Esophageal, Gastric and Duodenal Disorders (EGD) section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2012 in San Diego. We are now accepting volunteers for DDW 2012 abstract review and topic/speaker suggestions. Please visit the Volunteer and Feedback Form to get involved.
This year the EGD section accepted the majority of the abstracts submitted (76 percent). The accepted abstracts were designated as oral or poster presentations and of distinction based on their ranking by our dedicated abstract reviewers. The table below shows the change from last year:
|
EGD Abstract Selection |
2010 |
2011 |
|
Total Abstracts submitted |
661 |
682 |
|
Accepted Abstracts |
512 |
521 |
|
Oral Presentations |
111 |
128 |
|
Posters |
401 |
393 |
|
Posters of Distinction |
32 |
26 |
The EGD section sponsored Clinical and Translational Symposia, abstract based Research and Topic Fora, and one distinguished abstracts plenary. Our sessions were very well attended. The chart below outlines the sessions we sponsored at DDW 2011 and the number of people who attended the session. If you have feedback to share regarding any of these sessions please email Jennifer Gibson at AGA headquarters.
|
EGD Sessions |
|
|
|
Saturday, 5/7/2011 |
Duration |
Attendance |
|
Research Forum: Novel Virulence Factors and Host Pathways that Mediate H. pylori-induced Disease |
8:30 – 10 a.m. |
60 |
|
Research Forum: Novel Insights into Duodenal Mucosal Defense Mechanisms |
10:30 – 12 p.m. |
53 |
|
Research Forum: Extra-esophageal Manifestations of GERD |
2:15 – 3:45 p.m. |
231 |
|
Research Forum: Update in Non-variceal Upper GI Bleeding |
2:15 – 3:45 p.m. |
92 |
|
Research Forum: Novel Strategies to Guide Optimal Management of H. pylori-infected Persons |
4 – 5:30 p.m. |
100 |
|
Sunday, 5/8/2011 |
||
|
Research Forum: Advances in GERD Therapy |
8:30 – 10 a.m. |
187 |
|
Topic Forum: Novel Diagnostic and Therapeutic Applications of Esophageal Function Testing |
8:30 – 10 a.m. |
111 |
|
Research Forum: Update in Pathogenesis of Barrett's Metaplasia and Dysplasia |
8:30 – 10 a.m. |
99 |
|
Research Forum: Barrett's Esophagus and Cancer |
10:30 – 12 p.m. |
210 |
|
Research Forum: Immunopathogenesis of H. pylori Infections |
10:30 – 12 p.m. |
100 |
|
Research Forum: New Directions in Understanding Gastrointestinal Injury and Restitution |
10:30 – 12 p.m. |
45 |
|
Clinical Symposium: Eosinophilic Esophagitis: Update 2011 |
2:15 – 3:45 p.m. |
250 |
|
Research Forum: Improving Diagnostic Criteria for GERD |
2:15 – 3:45 p.m. |
90 |
|
Translational Symposium: Evolving Endoscopic, Surgical and Notes Techniques in Esophageal Diseases |
4 – 5:30 p.m. |
250 |
|
Monday, 5/9/2011 |
||
|
Research Forum: Complicated Motility Disorders |
2:15 – 3:45 p.m. |
120 |
|
Research Forum: Helicobacter pylori and Gastric Carcinogenesis |
2:15 – 3:45 p.m. |
130 |
|
Clinical Symposium: Management Quandaries in GERD |
2:15 – 3:45 p.m. |
400 |
|
Esophageal, Gastric and Duodenal Disorders Section Distinguished Abstracts Plenary |
4 – 5:30 p.m. |
70 |
|
Esophageal, Gastric and Duodenal Disorders Section Townhall Meeting |
5:30 – 6:30 p.m. |
unknown |
|
Tuesday, 5/10/2011 |
||
|
Clinical Symposium: Dyspepsia: Disease Definition and Outcome |
8:30 – 10 a.m. |
90 |
|
Research Forum: Evaluating Sequential Therapies for Eradication of H. pylori Infection |
8:30 – 10 a.m. |
120 |
|
Research Forum: Update in Pathogenesis of GERD |
8:30 – 10 a.m. |
100 |
|
Translational Symposium: Helicobacter pylori: Disease Modifiers and Optimal Therapies |
10:30 – 12 p.m. |
200 |
|
Research Forum: Novel Approaches to Functional Dyspepsia |
10:30 – 12 p.m. |
80 |
|
Research Forum: Risk Factors and Optimal Management of NSAID-induced Complications |
10:30 – 12 p.m. |
85 |
|
Research Forum: Diagnosis and Management of Barrett's Esophagus |
2:15 – 3:45 p.m. |
100 |
|
Research Forum: Eosinophilic Esophagitis: Advances in Therapeutic Approaches |
2:15 – 3:45 p.m. |
100 |
|
Research Forum: Endoscopy in Upper GI Disorders |
4 – 5:30 p.m. |
20 |
|
Research Forum: Eosinophilic Esophagitis: New Understanding in Pathogenesis |
4 – 5:30 p.m. |
55 |
|
Research Forum: Functional Dyspepsia: Assessment and Symptomatic Response |
4 – 5:30 p.m. |
60 |
|
Research Forum: GERD: Non-pharmacological Therapies |
4 – 5:30 p.m. |
60 |
|
Research Forum: New Animal Models of Mucosal Secretion, Injury and Repair |
4 – 5:30 p.m. |
35 |
Each June, EGD section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (EGD descriptors may change as we go forward to DDW 2012.) We would like to thank our abstract review Associate-chairs, Abstract Review Leaders, and reviewers for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Esophageal Disorders were shared at DDW.
|
Descriptor Name |
Abstracts Received |
Associate Chair |
Abstract Review Leader |
Abstract Reviewers |
|
GERD: Pathogenesis |
49 |
Jan Tack |
Jan Tack |
Peter Kahrilas, Roy Orlando, Justin Wu |
|
GERD: Diagnostic Testing |
43 |
Jan Tack |
Andreas Smout |
Ronnie Fass, John Pandolfino, Jan Tack |
|
GERD: Complications and Extra-esophageal Presentations |
31 |
Michael Vaezi |
Marcelo Vela |
David Armstrong, Ronnie Fass, Reza Shaker |
|
GERD: Pharmacological Treatment |
42 |
Michael Vaezi |
Franco Bazzoli |
Colin Howden, David Johnson, Peter Malfertheiner |
|
GERD: Non-pharmacological Therapies (Surgical, Intraluminal, Alternative and Others) |
9 |
Michael Vaezi |
Ravinder Mittal |
Ram Chuttani, Miguel Valdovinos |
|
GERD: Non-pharmacological Therapies (Surgical, Intraluminal, Alternative and Others) |
9 |
Michael Vaezi |
Ravinder Mittal |
Ram Chuttani, Miguel Valdovinos |
|
Barrett's Esophagus: Pathogenesis |
30 |
Kenneth Wang |
Rebecca Fitzgerald |
Ralf Kiesslich, Yvonne Romero, Joel Rubenstein, Rhonda Souza |
|
Barrett's-related Esophageal Adenocarcinoma |
32 |
Kenneth Wang |
Stuart Spechler |
Ganapathy Prasad, Doug Corley, Peter Siersema |
|
Acid-peptic Disorders |
20 |
Paul Moayyedi |
Colin Howden |
Ken DeVault, Alex Ford, Grigorios Leontiadis |
|
Dyspepsia: Clinical and Basic |
28 |
Paul Moayyedi |
Anthony Lembo |
Hiroto Miwa |
|
Eosinophilic Esophagitis and Gastroenteritis |
57 |
Ikuo Hirano |
David Katzka |
Evan Dellon, Glenn Furuta, Nirmala Gonsalves |
|
Non-variceal UGI Bleeding |
22 |
Ikuo Hirano |
Uri Ladabaum |
Michael Bourke, Francis Chan, John Fang |
|
NSAIDs: Clinical Evaluation and Treatment |
16 |
Byron Cryer |
Angel Lanas |
Jay Goldstein, Peter Konturek, Sandor Szabo |
|
NSAIDs: Outcomes Research |
8 |
Byron Cryer |
Loren Laine |
James Scheiman, Walter Smalley, C. Mel Wilcox |
|
Small Bowel Diseases: Diagnosis and Management |
10 |
Ikuo Hirano |
Joseph Murray |
Ciaran Kelly, Blair Lewis, Lawrence Schiller |
|
Mucosal Defense and Secretion |
19 |
Jonathan Kaunitz |
Yasutada Akiba |
Ludmila Filaretova, Markus Sjoblom, Koji Takeuchi |
|
Mucosal Injury, Repair and Healing |
46 |
Jonathan Kaunitz |
John Wallace |
Kikuko Amagase, Tetsuo Arakawa, Hui Dong, James Goldenring |
|
Helicobacter pylori: Epidemiology and Outcomes |
17 |
Ernst Kuipers |
Colm O'Morain |
Naoki Chiba, Elizabeth Fontham, Dulciene Queiroz |
|
Helicobacter pylori: Diagnosis, Treatment and Antimicrobial Resistance |
31 |
Ernst Kuipers |
Francis Megraud |
Javier Gisbert, Sibylle Koletzko, Sander van Zanten |
|
Helicobacter pylori-induced Host Responses and Disease |
27 |
JeanMarie Houghton |
John Kao |
Steven Czinn, Emad El-Omar, Steven Moss |
|
Helicobacter pylori: Virulence Factors and Pathogenesis |
14 |
JeanMarie Houghton |
Richard Ferrero |
Sheila Crowe, Guillermo Perez-Perez, Yoshio Yamaoka |
|
Endoscopic Approaches to Pre-malignant and Malignant UGI Disease |
9 |
Ikuo Hirano |
Uri Ladabaum |
Michael Bourke, Francis Chan, John Fang |
|
Dysmotility and other Non-reflux Esophageal Disorders* |
51 |
Ikuo Hirano |
Daniel Sifrim |
Guy Boeckxstaens, C. Prakash Gyawali, Ryan Madanick, Benson Massey |
|
Health Outcomes Research for Upper Endoscopy |
3 |
Jan Tack |
Doug Corley |
Steven Edmundowicz, Joel Rubenstein, Walter Smalley |
Note: Descriptors with an asterisk (*) are shared with at least one other Council section.
Section leaders will review committee membership this summer for new abstract review committees to confirm the final composition for DDW 2012 committees.
If you are interested in serving as a reviewer for any of our abstract descriptors for DDW 2012, please fill out this form to volunteer. Please indicate the abstract descriptor for which you are interested in reviewing. You can also recommend any new descriptors for abstracts. EGD section members interested in serving in this capacity are encouraged to contact us and volunteer to review abstracts. We are accepting volunteers through the end of July 2011. You can join the EGD section at any time.
In addition, we encourage you to submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please fill out this form to submit your suggestions to the AGA Institute by July 1, 2011.
Members interested in participating in the various activities of the EGD section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.
Thank you for your continuing strong support of the EGD section.
Sincerely,
Chair, EGD Section, AGA Institute Council
Vice-Chair, EGD Section, AGA Institute Council
